2013 annual financial data

Sarepta Therapeutics, Inc. 2013 Operating margin

Sarepta Therapeutics, Inc. 2013 operating margin with verified reported values.

Direct answer

Operating margin was -634.95%.

Operating income was -90,284,000 USD and net income was -111,985,000 USD.
Operating cash flow was -64,695,000 USD.

Get free Sarepta Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
14,219,000 USD
Operating income
-90,284,000 USD
Net income
-111,985,000 USD
Operating cash flow
-64,695,000 USD